BDSX.O (BDSX.O) News
Track canonical SquawkNews coverage tagged to BDSX.O, BDSX.O. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
BRIEF — Biodesix Advances Two Complementary Approaches To Molecular Residual Disease (Mrd) Monitoring
Sept 24 (Reuters) — Biodesix Inc: Biodesix Advances Two Complementary Approaches To Molecular Residual Disease (Mrd) Monitoring Source text:... Further company coverage: BDSX.O (Reuters.Briefs@thomsonreuters.com;)
NEWS | Sep 24, 2026, 10:06 AM UTC
L
Biodesix partners with Thermo Fisher on tumor — naïve MRD blood test program
Biodesix expanded its MRD strategy through collaborations with Bio-Rad for tumor-informed ctDNA monitoring and Thermo Fisher for a tumor-naïve assay. Bio-Rad program uses Droplet Digital PCR to track patient-specific tum
NEWS | Sep 24, 2026, 10:00 AM UTC